2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 482.095 | 136.013 | 156.260 | 172.298 | 188.006 | 191.926 | 168.776 | 159.193 | 188.210 | 280.418 |
Total Income - EUR | 489.748 | 136.199 | 156.300 | 174.950 | 192.307 | 203.724 | 343.506 | 183.531 | 188.235 | 280.443 |
Total Expenses - EUR | 504.091 | 104.598 | 112.794 | 119.210 | 131.917 | 136.506 | 370.994 | 202.239 | 242.626 | 157.530 |
Gross Profit/Loss - EUR | -14.343 | 31.600 | 43.505 | 55.740 | 60.390 | 67.218 | -27.488 | -18.707 | -54.392 | 122.913 |
Net Profit/Loss - EUR | -14.343 | 31.600 | 43.505 | 54.122 | 58.467 | 65.181 | -30.683 | -20.506 | -56.236 | 120.164 |
Employees | 22 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
Check the financial reports for the company - Comsutexin Sa
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 185.815 | 229.573 | 213.813 | 208.283 | 147.606 | 118.029 | 100.362 | 96.191 | 94.538 | 92.306 |
Current Assets | 66.222 | 33.849 | 56.263 | 70.019 | 50.957 | 84.917 | 26.798 | 27.930 | 28.353 | 71.056 |
Inventories | 32 | 32 | 32 | 32 | 31 | 30 | 0 | 0 | 0 | 0 |
Receivables | 32.088 | 22.011 | 21.156 | 19.931 | 30.696 | 37.540 | 17.941 | 27.370 | 19.373 | 37.371 |
Cash | 34.102 | 11.805 | 35.075 | 50.056 | 20.231 | 47.347 | 8.857 | 560 | 8.980 | 33.685 |
Shareholders Funds | 216.096 | 249.499 | 255.816 | 264.740 | 184.618 | 189.177 | 97.013 | 74.356 | 18.350 | 138.459 |
Social Capital | 20.445 | 20.616 | 20.405 | 20.060 | 19.692 | 19.310 | 18.944 | 18.524 | 18.582 | 18.525 |
Debts | 35.942 | 13.923 | 14.260 | 13.563 | 13.946 | 13.768 | 30.146 | 49.764 | 104.541 | 24.903 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4642 - 4642" | |||||||||
CAEN Financial Year |
6820
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Comsutexin Sa